We are live on ! Find out more
Jarislowsky, Fraser

Jarislowsky, Fraser Portfolio holdings

AUM $18.2B Turnover 3.11%
1-Year Est. Return 22.04%
 

Jarislowsky Fraser started in 1955 as a Montreal research firm that sold its stock research to investment managers in the US and UK. Its founder, Stephen Jarislowsky, was a Harvard-educated investor and former Alcan executive. The firm won its first pension fund client by 1966, and managing money for institutions became its core business. Scotiabank bought it in 2018, and the firm kept its Montreal headquarters and its investment independence. It looks for quality, sustainable businesses to hold for long-term growth, and serves pension funds, endowments, foundations, corporations and Indigenous communities.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+22.04%
3 Year Est. Return
+92.62%
5 Year Est. Return
+122.31%
10 Year Est. Return
+241.46%
AUM
$16.5B
AUM Growth
+$494M
Cap. Flow
-$180M
Cap. Flow %
-1.09%
Top 10 Hldgs %
46.94%
Holding
238
New
14
Increased
56
Reduced
132
Closed
15
Avg Time Held
3.4 years
Top 10 Avg Time Held
3.6 years
Top 20 Avg Time Held
3.5 years

Top Buys

Rank Stock Value
1
BN icon
Brookfield
BN
+$107M
2
BSX icon
Boston Scientific
BSX
+$52M
3
OZK icon
Bank OZK
OZK
+$35.6M
4
NTR icon
Nutrien
NTR
+$24.1M
5
UNH icon
UnitedHealth
UNH
+$23.9M

Top Sells

Rank Stock Value
1
WBA icon
Walgreens Boots Alliance
WBA
+$73.5M
2
CVS icon
CVS Health
CVS
+$46.3M
3
TD icon
Toronto Dominion Bank
TD
+$35.2M
4
TFC icon
Truist Financial
TFC
+$33.6M
5
MDT icon
Medtronic
MDT
+$28.2M

Sector Composition

Rank Sector Weight
1 Financials 30.29%
2 Industrials 15.36%
3 Energy 13.61%
4 Technology 13.14%
5 Healthcare 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TD icon
1
Toronto Dominion Bank
TD
$202B
$1.18B 7.13%
20,079,722
-626,349
-3% -$35.2M
2016 Q3
11 quarters
CNI icon
2
Canadian National Railway
CNI
$76.3B
$927M 5.63%
9,999,018
-265,708
-3% -$24.4M
2013 Q2
24 quarters
RY icon
3
Royal Bank of Canada
RY
$280B
$879M 5.33%
11,034,904
-321,609
-3% -$25.1M
2016 Q3
11 quarters
ENB icon
4
Enbridge
ENB
$106B
$836M 5.07%
23,097,538
-659,111
-3% -$24M
2013 Q2
24 quarters
BNS icon
5
Scotiabank
BNS
$113B
$791M 4.8%
14,697,980
-438,678
-3% -$23.4M
2013 Q2
24 quarters
MFC icon
6
Manulife Financial
MFC
$72.8B
$645M 3.92%
35,440,777
-980,227
-3% -$17.4M
2013 Q2
24 quarters
NTR icon
7
Nutrien
NTR
$33.8B
$645M 3.91%
12,026,152
+461,871
+4% +$24.1M
2018 Q1
5 quarters
OTEX icon
8
Open Text
OTEX
$6B
$639M 3.88%
15,461,971
-346,680
-2% -$13.8M
2013 Q2
24 quarters
BN icon
9
Brookfield
BN
$91.5B
$622M 3.77%
36,347,772
+6,332,037
+21% +$107M
2016 Q4
10 quarters
GIB icon
10
CGI
GIB
$16.7B
$575M 3.49%
7,468,737
-197,242
-3% -$14.3M
2014 Q4
18 quarters
TRI icon
11
Thomson Reuters
TRI
$47.4B
$575M 3.49%
8,440,592
-153,378
-2% -$10.2M
2016 Q3
11 quarters
GIL icon
12
Gildan
GIL
$6.42B
$490M 2.97%
12,633,481
-289,761
-2% -$10.8M
2015 Q1
17 quarters
CNQ icon
13
Canadian Natural Resources
CNQ
$101B
$483M 2.93%
36,505,379
-1,230,038
-3% -$16.9M
2013 Q2
24 quarters
QSR icon
14
Restaurant Brands International
QSR
$26.3B
$482M 2.93%
6,922,173
-109,155
-2% -$7.31M
2018 Q3
3 quarters
PBA icon
15
Pembina Pipeline
PBA
$29.3B
$423M 2.57%
11,347,967
-261,276
-2% -$9.5M
2013 Q3
23 quarters
MSFT icon
16
Microsoft
MSFT
$3.89T
$317M 1.93%
2,370,019
+111,576
+5% +$14.2M
2013 Q2
24 quarters
CAE icon
17
CAE Inc
CAE
$8.92B
$290M 1.76%
10,763,558
-373,640
-3% -$9.13M
2013 Q2
24 quarters
STN icon
18
Stantec
STN
$9.48B
$285M 1.73%
11,846,556
-262,698
-2% -$6.34M
2016 Q3
11 quarters
JPM icon
19
JPMorgan Chase
JPM
$919B
$218M 1.32%
1,946,683
-1,412
-0.1% -$156K
2013 Q2
24 quarters
PEP icon
20
PepsiCo
PEP
$198B
$203M 1.23%
1,549,578
+124,793
+9% +$16M
2013 Q2
24 quarters
JNJ icon
21
Johnson & Johnson
JNJ
$688B
$184M 1.12%
1,324,158
-25,174
-2% -$3.48M
2013 Q2
24 quarters
VRSK icon
22
Verisk Analytics
VRSK
$26.7B
$184M 1.11%
1,253,236
+3,744
+0.3% +$528K
2016 Q3
11 quarters
ABT icon
23
Abbott
ABT
$188B
$180M 1.09%
2,145,365
+6,372
+0.3% +$502K
2013 Q2
24 quarters
BDX icon
24
Becton Dickinson
BDX
$59.4B
$179M 1.09%
729,922
+37,255
+5% +$8.66M
2013 Q2
24 quarters
ORCL icon
25
Oracle
ORCL
$391B
$167M 1.02%
2,937,268
+17,378
+0.6% +$940K
2013 Q2
24 quarters

Similar funds

Jarislowsky, Fraser's Q2 2019 Portfolio in Review

As of Q2 2019, Jarislowsky, Fraser held 238 positions worth $16.5B, up 3.1% from $16B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Jarislowsky, Fraser's Q2 2019 filing shows 14 new, 56 increased, 132 reduced and 15 closed positions. Its largest new stake was Boston Scientific: 1,352,843 shares worth $58.1M. The largest sale was Walgreens Boots Alliance, an estimated $73.5M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Industrials and Energy.

  • Jarislowsky, Fraser's largest Q2 2019 buy was Boston Scientific: 1,352,843 shares worth $58.1M.
  • Jarislowsky, Fraser added most to Brookfield in Q2 2019, an estimated $107M increase.
  • Jarislowsky, Fraser's biggest Q2 2019 reduction was Walgreens Boots Alliance, cutting an estimated $73.5M.
  • Jarislowsky, Fraser fully exited iShares Expanded Tech Sector ETF in Q2 2019, selling an estimated $1.7M.
  • Jarislowsky, Fraser's ten largest holdings make up 47% of its $16.5B portfolio in Q2 2019.
  • Jarislowsky, Fraser opened 14 new positions and closed 15 in Q2 2019.
  • Jarislowsky, Fraser's portfolio value rose 3.1% quarter-over-quarter to $16.5B.

Based on Jarislowsky, Fraser's 13F filing for Q2 2019, filed 13 Aug 2019.